Furosemide (sc bolus or syringe driver)

Amber-G

Brand Name(s):

Indication:Management of heart failure only when initiated by Palliative Care Service

Rationale:

Considered:Jan-12

Review Date:Apr-21

Comments:
Refer to prescribing guidance on website.
This guidance has been developed by the Palliative Care Team and relates to sub cutaneous furosemide either by bolus or syringe sriver in the management of heart failure.